Cyndeo Wealth Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.5M Buy
137,211
+305
+0.2% +$65.6K 1.63% 6
2026
Q1
$29.8M Buy
136,906
+5,016
+4% +$1.11M 1.57% 7
2025
Q4
$30.1M Sell
131,890
-50
-0% -$11.4K 1.62% 8
2025
Q3
$30.5M Buy
131,940
+706
+0.5% +$144K 1.7% 6
2025
Q2
$24.4M Buy
131,234
+1,536
+1% +$285K 1.44% 8
2025
Q1
$27.2M Sell
129,698
-7,215
-5% -$1.4M 1.78% 6
2024
Q4
$24.3M Buy
136,913
+954
+0.7% +$175K 1.64% 6
2024
Q3
$26.8M Sell
135,959
-4,914
-3% -$917K 1.88% 4
2024
Q2
$24.2M Buy
140,873
+3,178
+2% +$526K 1.89% 5
2024
Q1
$25.1M Buy
137,695
+716
+0.5% +$123K 2.09% 4
2023
Q4
$21.2M Buy
136,979
+10,863
+9% +$1.58M 1.96% 6
2023
Q3
$18.8M Sell
126,116
-18,670
-13% -$2.74M 1.96% 5
2023
Q2
$19.5M Buy
144,786
+7,817
+6% +$1.15M 2.04% 6
2023
Q1
$21.8M Buy
136,969
+37,296
+37% +$5.7M 2.35% 4
2022
Q4
$16.1M Buy
+99,673
New +$15.3M 1.89% 6

Other funds holding ABBV

Cyndeo Wealth Partners's ABBV Position: Q2 2026 in Review

Cyndeo Wealth Partners increased its AbbVie (ABBV) stake by 0.22% in Q2 2026, buying an estimated $65.6K and bringing the position to 137,211 shares worth $34.5M. The position accounts for 1.63% of the portfolio, ranked #6.

Cyndeo Wealth Partners first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Cyndeo Wealth Partners held 137,211 shares of AbbVie worth $34.5M as of Q2 2026.
  • Cyndeo Wealth Partners bought 305 AbbVie shares in Q2 2026, an estimated $65.6K.
  • AbbVie made up 1.63% of Cyndeo Wealth Partners's portfolio in Q2 2026, its #6 holding.
  • Cyndeo Wealth Partners first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cyndeo Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.